Navigation Links
Shares of Oramed Pharmaceuticals Are Approved for Listing on the Nasdaq Capital Market
Date:2/7/2013

JERUSALEM, February 7, 2013 /PRNewswire/ --

Oramed Pharmaceuticals Inc. (OTCQB: ORMPD), a developer of oral drug delivery systems, announced today that NASDAQ has approved the company's application to list its shares of common stock on the NASDAQ Capital Market. The company's shares of common stock will begin trading on the Nasdaq Capital Market under the symbol ORMP (formerly OTCQB: ORMPD) starting on Monday, February 11, 2013.

"Oramed is ready to begin trading on a higher profile exchange like NASDAQ," noted Nadav Kidron , CEO of Oramed. "We are very excited and believe that this is the right marketplace for our shares. Listing on NASDAQ should enable us to broaden our investor reach and increase visibility and liquidity of our shares."

About Oramed Pharmaceuticals

Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs and vaccines currently delivered via injection. Established in 2006, Oramed's technology is based on over 30 years of research by top research scientists at Jerusalem's Hadassah Medical Center. Oramed is seeking to revolutionize the treatment of diabetes through its proprietary flagship product, an orally ingestible insulin capsule (ORMD-0801) currently approaching FDA-approved Phase 2 clinical trials, and with its oral exenatide capsule (ORMD-0901; a GLP-1 analog), currently approaching Phase 1b/2a trials. The company's corporate and R&D headquarters are based in Jerusalem.

Forward-looking statements: This press release contains forward-looking statements. For example, we are using forward-looking statements when we discuss our listing on Nasdaq and how such listing would enable us to broaden our investor reach and increase visibility and liquidity of our shares, or when we discuss that our products are approaching FDA-appr
'/>"/>

SOURCE Oramed Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Free Research Report on Ford Motor Co., Pfizer, Inc., Barclays Bank PLC, General Electric Co. and PowerShares QQQ Trust
2. AspenBio Pharma Announces Closing of Public Offering of 1,946,000 Shares of Common Stock
3. AspenBio Pharma Announces Pricing of Public Offering of 1,476,000 Shares of Common Stock
4. IRIDEX Announces Tender Offer to Purchase up to 487,500 Shares of its Common Stock
5. Southern Home Medical Once Again Reduces The Companys Issued And Outstanding Preferred Shares
6. As Deadline Approaches, Practice Fusion Shares Meaningful Use Stories
7. Generex Addresses Recent Trading Volume in Shares of its Common Stock
8. MAP Pharmaceuticals, Inc. Announces Full Exercise of Underwriters Option to Purchase Additional Shares of Common Stock
9. Varian Medical Systems Board of Directors Authorizes Repurchase of Additional 8 Million Shares of Stock through Calendar Year 2013
10. iMD Companies Inc. receives shares of Positive Solutions
11. Silence Therapeutics - Admission of Shares and Board Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... July 31, 2014  Zacks.com announces the list of stocks ... Research analysts discuss the latest news and events impacting stocks ... include the Biogen (Nasdaq: BIIB - Free Report ), Gilead ... PBYI - Free Report ), AbbVie (NYSE: ABBV ... Free Report ). Today, Zacks is promoting its ...
(Date:7/31/2014)... YORK , July 31, 2014 TB ... better, faster and affordable treatments for tuberculosis (TB), announced ... Vice President, Market Access. Ms. Robertson joins the organization ... company,s business in Sub-Saharan Africa and Eastern ... oversee the TB Alliance,s efforts to ensure beneficial new ...
(Date:7/31/2014)... und KISSING, Deutschland, 31. Juli ... und Distributor eines computerunterstützten („robotischen") Koloskopie-Systems für ... (Homi) Shamir , ein weltweit anerkannter Manager ... und Kontrollgremiums zum Unternehmen stößt. ... Shamir ist ein hochangesehener globaler Visionär ...
Breaking Medicine Technology:The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 2The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 3The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 4The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 5The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 6TB Alliance Names Elana Robertson Senior Vice President, Market Access 2TB Alliance Names Elana Robertson Senior Vice President, Market Access 3invendo medical holt Nachum (Homi) Shamir in den Board of Directors des Unternehmens 2invendo medical holt Nachum (Homi) Shamir in den Board of Directors des Unternehmens 3
... 4, 2011 Bioness Inc. today ... of the FASTEST study to further examine the impact of ... drop as a result of stroke. The FASTEST study aims ... System over standard therapy with an ankle-foot orthosis (AFO), and ...
... Inc. (NASDAQ: NBIX ) today announced that it ... for elagolix and next-generation Gonadotropin Releasing Hormone (GnRH) Receptor Antagonists. ... with the FDA, the outcome of which generated a $20 ... event brings the total milestones achieved by the Company in ...
Cached Medicine Technology:Bioness Inc. Announces Completion of Enrollment in Its FASTEST L300 Study 2Neurocrine Biosciences Receives Second Milestone Payment of $20 Million Under Abbott Collaboration Agreement 2
(Date:7/31/2014)... 31, 2014 Researchers from the ... largest study to date comparing the ... or traditional letter referral systems in a real-life ... patent pending iDoc24® technology provided faster and more ... while potentially eliminating unnecessary visits. iDoc24® is a ...
(Date:7/31/2014)... Reserve University medical and nursing school researchers hope ... patients who participate in clinical trials, a critical ... preventions. , For various reasonsincluding a lack of ... of cancer patients take part in trials of ... cancer patients who are eligible still don,t enroll, ...
(Date:7/31/2014)... Thousands of independent community pharmacists, ... have come together today to kick off ThoughtSpot ... , "ThoughtSpot 2014 is Good Neighbor Pharmacy’s annual ... to help their businesses thrive," stated AJ Caffentzis, ... long-standing commitment to independent community pharmacies, and at ...
(Date:7/31/2014)... New Delhi, India (PRWEB) July 31, 2014 ... Web Technologies, an ISO 9001:2008 certified internet marketing firm, ... Designing. In order to make this service affordable for ... in return of the service. , Web Programming ... study about the world of brochure designing and likely ...
(Date:7/31/2014)... 2014 Recently, Agebc.com, a popular online shop ... its new selection of trendy mother of the bride ... at promotional prices now, up to 68% off. , ... the new range of mother of the bride dresses. We ... clients. So far, our online shop has received thousands of ...
Breaking Medicine News(10 mins):Health News:Smartphone iDoc 24 Technology Speeds Time to Diagnosis and Treatment for Skin Cancer Patients 2Health News:Smartphone iDoc 24 Technology Speeds Time to Diagnosis and Treatment for Skin Cancer Patients 3Health News:Smartphone iDoc 24 Technology Speeds Time to Diagnosis and Treatment for Skin Cancer Patients 4Health News:$1.6 million NCI grant to CWRU trains nurses to increase participation in clinical trials 2Health News:$1.6 million NCI grant to CWRU trains nurses to increase participation in clinical trials 3Health News:Good Neighbor Pharmacy’s ThoughtSpot Begins Today with Record Attendance 2Health News:Good Neighbor Pharmacy’s ThoughtSpot Begins Today with Record Attendance 3Health News:Web Programming Services Introduces Affordable Brochure Designing Service 2Health News:Mother of the Bride Dresses Now Available With Great Discounts at Agebc.com 2
... Inc. (OTC Bulletin Board: NVLX), today announced that it will ... at 4:30 PM Eastern Time to discuss current trends in ... of the Last Shot Hangover Remedy. , , ... extraordinary progress towards achieving our stated goals for the current ...
... ... launches a new national television advertising campaign calling on Congress to put an end ... ... -- Autism Speaks, the nation,s largest autism science and advocacy organization, today launched a ...
... more aggressive cancer, study contends , WEDNESDAY, July 8 (HealthDay ... prescribing the drug finasteride to men at risk for prostate ... when trying to decide whether to use the drug, which ... in five men who take it. However, findings from the ...
... mother and she,ll tell you that raising a preschooler is ... like to bring up a child with autism or a ... Center asked mothers about their experiences and found that moms ... and psychological distress than mothers of children with developmental delay. ...
... Like an estimated 5 million other Americans, Barry Simonis had ... risk of stroke and causes the most important muscle in ... cardiovascular surgeon John Johnkoski, M.D., recently performed an advanced surgical ... that plagued the Rosholt resident for more than 10 years. ...
... avoid arthritis in adolescence , WEDNESDAY, July 8 (HealthDay News) ... reduce their risk of developing early arthritis, says a new ... defect in newborns -- occurs when a hip joint is ... with the condition can develop arthritis of the hip when ...
Cached Medicine News:Health News:Nuvilex, Inc. Announces Business Update Conference Call 2Health News:Nuvilex, Inc. Announces Business Update Conference Call 3Health News:Autism Speaks Launches TV Ad Campaign Calling on Congress to End Insurance Discrimination Against Children with Autism 2Health News:Autism Speaks Launches TV Ad Campaign Calling on Congress to End Insurance Discrimination Against Children with Autism 3Health News:Prostate Drug Appears Safer Than Thought 2Health News:Mothers of children with autism have higher parental stress, psychological distress 2Health News:Mothers of children with autism have higher parental stress, psychological distress 3Health News:Advanced Heart Procedure Treats Growing Problem 2Health News:Advanced Heart Procedure Treats Growing Problem 3Health News:Screen All Newborns for Hip Dysplasia, Study Urges 2
Hand surgery basic instrument set with round handled instruments...
Rhoton microscopic forceps, straight...
Quick release, easy to close 2" webbing and buckle. Available in teal, royal, red, purple, and maroon nylon stain-resistant fabric or navy nylon reinforced vinyl....
Velcro closures on each side to more evenly distribute the weight. Available in teal, royal, red, purple, or maroon nylon stain-resistant fabric or navy nylon reinforced vinyl....
Medicine Products: